Delacrétaz F, Schmidt P M, Piguet D, Bachmann F, Costa J
Am J Clin Pathol. 1987 Feb;87(2):180-6. doi: 10.1093/ajcp/87.2.180.
Twenty-eight cases of myelodysplastic syndrome (MDS) were reviewed to evaluate whether the morphologic criteria proposed by the French-American-British (FAB) Cooperative Group for marrow smears could be applied to glycol methacrylate embedded trephine biopsies. Bone marrow biopsies and marrow smears were examined separately and then compared for the following parameters: percentage of blasts, dyserythropoiesis, ring sideroblasts, dysmegakaryopoiesis, dysgranulopoiesis, monocytes, cellularity, fibrosis, and "abnormal localization of immature precursors". The results of the histologic (biopsies) and cytologic (marrow smears) examinations were in good agreement in 24 of 28 cases. The authors' results suggest that the five MDS types proposed by the FAB group can be reliably distinguished on bone marrow biopsy with knowledge of the peripheral blood blast and monocyte counts. When the bone marrow aspiration is inadequate, the biopsy can establish diagnosis and type of MDS and rules out aplasia or tumor infiltration as possible alternative causes of cytopenia.
回顾了28例骨髓增生异常综合征(MDS)病例,以评估法国-美国-英国(FAB)协作组提出的骨髓涂片形态学标准是否可应用于甲基丙烯酸乙二醇酯包埋的骨髓活检组织。分别检查骨髓活检组织和骨髓涂片,然后比较以下参数:原始细胞百分比、红细胞生成异常、环形铁粒幼细胞、巨核细胞生成异常、粒细胞生成异常、单核细胞、细胞密度、纤维化以及“幼稚前体细胞异常定位”。组织学(活检)和细胞学(骨髓涂片)检查结果在28例中的24例中高度一致。作者的结果表明,了解外周血原始细胞和单核细胞计数后,FAB组提出的五种MDS类型可在骨髓活检中可靠区分。当骨髓穿刺不足时,活检可确立MDS的诊断和类型,并排除再生障碍性贫血或肿瘤浸润作为血细胞减少的可能替代病因。